000 01397 a2200421 4500
005 20250513162213.0
264 0 _c19990208
008 199902s 0 0 eng d
022 _a0344-5704
024 7 _a10.1007/s002800050871
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWagner, M M
245 0 0 _aIn vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines.
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_c1999
300 _a115-25 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xchemistry
650 0 4 _aCell Cycle
_xdrug effects
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aColony-Forming Units Assay
650 0 4 _aDepsipeptides
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Resistance, Multiple
650 0 4 _aFlow Cytometry
650 0 4 _aHumans
650 0 4 _aLactams
_xchemistry
650 0 4 _aLactones
_xchemistry
650 0 4 _aMicroscopy, Fluorescence
650 0 4 _aMolecular Structure
650 0 4 _aTumor Cells, Cultured
700 1 _aPaul, D C
700 1 _aShih, C
700 1 _aJordan, M A
700 1 _aWilson, L
700 1 _aWilliams, D C
773 0 _tCancer chemotherapy and pharmacology
_gvol. 43
_gno. 2
_gp. 115-25
856 4 0 _uhttps://doi.org/10.1007/s002800050871
_zAvailable from publisher's website
999 _c9885467
_d9885467